HealthTech platform Hublo secures €40 million Revaia reinvestment to support post-exit growth phase

February 3, 2026 at 12:24 PM UTC
EU-Startups
Original: EN
HealthTech platform Hublo secures €40 million Revaia reinvestment to support post-exit growth phase

European HealthTech sees significant investment as workforce management platform Hublo secures a substantial €40 million reinvestment from growth investor Revaia. This significant funding underscores Revaia's long-term commitment to Hublo, extending support beyond its initial holding period and signaling confidence in the company's post-exit growth trajectory. This move highlights a trend towards deeper, ownership-driven investments in established European digital health solutions. The reinvestment will enable Hublo to further develop its workforce management software for the healthcare sector, a critical area given persistent staffing shortages. Founded in 2016, Hublo offers a comprehensive platform for recruitment, scheduling, and internal mobility, reportedly saving users an average of 2.5 hours per day. The platform has seen widespread adoption, serving over 22,000 managers across 5,000 facilities and benefiting one million healthcare professionals. This substantial funding contrasts with other recent European HealthTech rounds, which have been generally smaller in scale. For instance, Doctor.One raised €4 million for its asynchronous care model, while Mindoo secured €5 million for its AI-driven workload reduction solutions. Hublo's €40 million vehicle, however, points to a strategic, later-stage investment focused on continued value creation within a mature digital health player.

Curated and translated by Europe Digital for our multilingual European audience.

Source Information

Publication: EU-Startups
Published: February 3, 2026 at 12:24 PM UTC
All rights remain with the original publisher.